Country: France
Language: English
Source: HMA (Heads of Medicines Agencies)
enrofloxacin 100 mg/ml
CEVA Sante Animale
QJ01MA90
Oral solution
enrofloxacin
Chicken, Turkeys
2012-06-01
1/4 SUMMARY OF PRODUCT CHARACTERISTICS (S.P.C.) 1. NAME OF THE VETERINARY MEDICINAL PRODUCT QUINOFLOX® 10% SOLUTION BUVABLE (FR) QUINOFLOX 100 MG/ML BELSÖLEGES OLDAT A.U.V (HU) CEVAFLOX 10% SOLUZIONE ORALE (IT) QUINOFLOX 100 MG/ML GERIAMASIS TIRPALAS (LT) QUINOFLOX 100 MG/ML ŠĶĪDUMS IEKŠĶĪGAI LIETOŠANAI (LV) QUINOFLOX 100 MG/ML PERORALNA RAZTOPINA (SI) QUINOFLOX 100 MG/ML PERRAALNE LAHUS (EE) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of product contains : Enrofloxacin ...................................................... 100 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Yellow-green oral solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens and turkeys. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Chickens and turkeys : Treatment of respiratory diseases caused by _Mycoplasma gallisepticum, _ _Mycoplasma _ _synoviae and E. coli. _ _ _ Chickens (pullets) : Treatment of genital diseases caused by _Escherichia coli_. 4.3 CONTRAINDICATIONS Do not use in case of resistance to quinolones. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 2/4 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Wherever possible, fluoroquinolones should be used based on susceptibility testing. Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to othe Read the complete document